Cargando…
MMP2 as an independent prognostic stratifier in oral cavity cancers
BACKGROUND: Around 25% of oral cavity squamous cell carcinoma (OCSCC) are not controlled by the standard of care, but there is currently no validated biomarker to identify those patients. Our objective was to determine a robust biomarker for severe OCSCC, using a biology-driven strategy. PATIENTS AN...
Autores principales: | Hoffmann, Caroline, Vacher, Sophie, Sirven, Philémon, Lecerf, Charlotte, Massenet, Lucile, Moreira, Aurélie, Surun, Aurore, Schnitzler, Anne, Klijanienko, Jerzy, Mariani, Odette, Jeannot, Emmanuelle, Badois, Nathalie, Lesnik, Maria, Choussy, Olivier, Le Tourneau, Christophe, Guillot-Delost, Maude, Kamal, Maud, Bieche, Ivan, Soumelis, Vassili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466851/ https://www.ncbi.nlm.nih.gov/pubmed/32934875 http://dx.doi.org/10.1080/2162402X.2020.1754094 |
Ejemplares similares
-
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity
por: Hoffmann, Caroline, et al.
Publicado: (2022) -
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
por: Leblanc, Olivia, et al.
Publicado: (2020) -
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
por: Neuzillet, Cindy, et al.
Publicado: (2021) -
Definition of a novel breast tumor-specific classifier based on secretome analysis
por: Sirven, Philémon, et al.
Publicado: (2022) -
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
por: Moreira, A., et al.
Publicado: (2021)